GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jushi Holdings Inc (OTCPK:JUSHF) » Definitions » Debt-to-EBITDA

Jushi Holdings (Jushi Holdings) Debt-to-EBITDA : 22.89 (As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Jushi Holdings Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Jushi Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $100.1 Mil. Jushi Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $198.7 Mil. Jushi Holdings's annualized EBITDA for the quarter that ended in Dec. 2023 was $13.1 Mil. Jushi Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 22.89.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Jushi Holdings's Debt-to-EBITDA or its related term are showing as below:

JUSHF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -2.64   Med: 1.04   Max: 9.85
Current: 9.79

During the past 13 years, the highest Debt-to-EBITDA Ratio of Jushi Holdings was 9.85. The lowest was -2.64. And the median was 1.04.

JUSHF's Debt-to-EBITDA is ranked worse than
93.02% of 659 companies
in the Drug Manufacturers industry
Industry Median: 1.66 vs JUSHF: 9.79

Jushi Holdings Debt-to-EBITDA Historical Data

The historical data trend for Jushi Holdings's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jushi Holdings Debt-to-EBITDA Chart

Jushi Holdings Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.54 2.63 -2.64 9.85

Jushi Holdings Quarterly Data
Feb19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.67 5.69 6.40 26.97 22.89

Competitive Comparison of Jushi Holdings's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Jushi Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jushi Holdings's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jushi Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Jushi Holdings's Debt-to-EBITDA falls into.



Jushi Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Jushi Holdings's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(100.092 + 198.741) / 30.349
=9.85

Jushi Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(100.092 + 198.741) / 13.056
=22.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Jushi Holdings  (OTCPK:JUSHF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Jushi Holdings Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Jushi Holdings's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Jushi Holdings (Jushi Holdings) Business Description

Traded in Other Exchanges
Address
301 Yamato Road, Suite 3250, Boca Raton, FL, USA, 33431
Jushi Holdings Inc is a vertically integrated multi-state cannabis and hemp operator across the United States. The company operates a diverse portfolio of branded cannabis and hemp-derived assets, built upon opportunistic acquisitions, distressed deals and competitive applications. Operating under the Jushi umbrella is the BEYOND / HELLO retail brand of cannabis dispensaries, hemp-based CBD brand, Nira, including its brands, The Lab: Concentrates and The Bank: Flower + Genetics, as well as its precision formulated line of medical cannabis products Nira Plus. Jushi strives to maximize shareholder value while delivering high premium products across all levels of the cannabis and hemp ecosystem.